EXIDINE Drug Patent Profile
When do Exidine patents expire, and what generic alternatives are available?
Exidine is a drug marketed by Xttrium and is included in two NDAs.
The generic ingredient in EXIDINE is chlorhexidine gluconate. There is one drug master file entry for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Exidine
A generic version of EXIDINE was approved as chlorhexidine gluconate by BECTON DICKINSON on October 24th, 1989.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for EXIDINE?
- What are the global sales for EXIDINE?
- What is Average Wholesale Price for EXIDINE?
Summary for EXIDINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 42 |
| DailyMed Link: | EXIDINE at DailyMed |
Pharmacology for EXIDINE
| Physiological Effect | Decreased Cell Wall Integrity |
US Patents and Regulatory Information for EXIDINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xttrium | EXIDINE | chlorhexidine gluconate | AEROSOL, METERED;TOPICAL | 019127-001 | Dec 24, 1984 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Xttrium | EXIDINE | chlorhexidine gluconate | SOLUTION;TOPICAL | 019421-001 | Dec 17, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
